Description
A potent OX1R antagonist (Ki = 26.9 nM in a calcium mobilization assay); selective for OX1R over OX2R (Kds = 21.7 and 1,704 nM, respectively, in a radioligand binding assay); co-perfusion with human OX1R in rat ventral tegmental area inhibits OX1R-induced glutamate and dopamine elevations; reduces cocaine-seeking behavior in rats
Formal name: N-(6,8-difluoro-2-methyl-4-quinolinyl)-N’-[4-(dimethylamino)phenyl]-urea
Synonyms:
Molecular weight: 356.4
CAS: 288150-92-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Neuroscience|Behavioral Neuroscience|Addiction Research||Research Area|Neuroscience|Neuroendocrinology